Clinical, angiographic and CMR characteristics of the patients with STEMI
| Details | Number |
|---|---|
| Number of patients | 40 |
| Male (%) | 35 (88%) |
| Age (year) | 59±13 |
| Diabetes mellitus | 8 (20%) |
| Hypertension | 14 (35%) |
| Smoking | 12 (30%) |
| Dyslipidaemia | 14 (35%) |
| Chest pain onset to PPCI time (minutes) | 267 (122–330) |
| Infarct artery (%) | |
| LAD | 24 (60%) |
| RCA | 14 (35%) |
| Cx | 2 (5%) |
| TIMI flow pre-PPCI/post-PPCI (%) | |
| 0 | 33 (83%)/1 (3%) |
| 1 | 0 (0%)/0 (0%) |
| 2 | 3 (8%)/8 (20%) |
| 3 | 4 (10%)/31 (78%) |
| CMR findings | |
| LV EDV (mL) | |
| Acute | 172±38 |
| Follow-up | 182±49* |
| LV ESV (mL) | |
| Acute | 90±30 |
| Follow-up | 88±38 |
| LV EF (%) | |
| Acute | 49±8 |
| Follow-up | 53±10* |
| LV mass (g) | |
| Acute | 112±35 |
| Follow-up | 104±26 |
| Reference MI size (%LV) | |
| Acute | 25.0±13.7 |
| Follow-up | 17.3±10.1* |
| MVO (%) | 26 (65%) |
*Denotes statistically significant difference between the acute and follow-up values. Actual p values previously reported.18
CMR, cardiovascular magnetic resonance; Cx, circumflex artery; EDV, end diastolic volume; EF, ejection fraction; ESV, end systolic volume; LAD, left anterior descending artery; LV, left ventricular; MI, myocardial infarct; MVO, microvascular obstruction; RCA, right coronary artery; STEMI, ST segment elevation myocardial infarction; TIMI, thrombolysis in myocardial infarction.
PPCI: primary percutaneous coronary intervention